drugset / Trial / NCT00003775

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

NCT00003775

Phase 2 Completed 60 enrolled Pfizer National Cancer Institute (NCI) · collab
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of leflunomide in treating patients who have anaplastic astrocytoma in first relapse.

Timeline

Start
1998-12
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Leflunomide Small molecule Intravenous